Evidence map›Paper›PMID 41796189›Full record

ArticleScientific reports2026

FMCL: a transformer-based feature-map classifier learning approach for enhanced brain tumor detection in MRI.

Turki M Alanazi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Turki M AlanaziDepartment of Electrical Engineering, College of Engineering, University of Hafr Al Batin, 39524, Hafr Al Batin, Saudi Arabia. trmalanazi@uhb.edu.sa.

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia 0018-1446-S
6 · The paper itself

Abstract

In order to achieve a higher level of precision in the diagnosis of brain tumors using magnetic resonance imaging (MRI) data, both traditional image processing and advanced machine learning techniques are utilized. This enables adaptive identification of regions based on relationships between extracted features. In this article, we propose a Feature-Map Contrast Learning (FMCL) framework for improved brain tumor identification. Unlike conventional CNN- or transformer-based methods, FMCL explicitly enforces an inverse proportional relationship between contrast and intensity during feature extraction, preventing feature domination in heterogeneous or low-contrast tumor regions. A proportionate correlation between contrast and intensity is maintained across a large number of classification cases. FMCL performs a multi-class classification of brain MRI images, distinguishing multiple tumor types and healthy tissue by integrating transformer-based self-attention over regulated feature maps, which enhances spatial coherence and tumor boundary localization. During classification, transformer learning differentiates high, low, and zero classification possibilities, and adjacent-region verification with SoftMax normalization further improves segmentation reliability. By utilizing maximal alterations across feature maps, classed regions are accurately recognized and segmented as tumor-infected. To achieve optimal detection precision, FMCL is trained using multiple classification outputs while traversing pixels. The proposed FMCL approach demonstrates improved performance, enhancing accuracy by 8.85% and 8.3%, while reducing mean error by 16.19%, compared to existing methods. The proposed FMCL framework was evaluated using the Kaggle Brain Tumor MRI Dataset, which contains 3264 MRI images of 512 × 512 pixels, including classes for No Tumor, Glioma, Meningioma, and Pituitary tumors.

Indexed as

Brain NeoplasmsImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMachine LearningMagnetic Resonance ImagingClassification AlgorithmsConvolutional Neural NetworksHumansBrain tumorFeature mapMagnetic resonance imagingSoftMax functionTransformer learning

Identifiers

PMID41796189
PMCPMC13086971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.